Section Arrow
HAE.NYSE
- Haemonetics Corp
Quotes are at least 15-min delayed:2026/01/24 23:42 EST
Regular Hours
Last
 68.82
-1.2 (-1.71%)
Day High 
70.62 
Prev. Close
70.02 
1-M High
86.11 
Volume 
956.84K 
Bid
67.5
Ask
76
Day Low
68.53 
Open
70 
1-M Low
69.78 
Market Cap 
3.28B 
Currency 美元 
P/E 20.47 
%Yield -- 
10-SMA 75.99 
20-SMA 78.51 
50-SMA 78.97 
52-W High 87.32 
52-W Low 47.315 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
3.42/5.45
Enterprise Value
4.20B
Balance Sheet
Book Value Per Share
18.14
Cash Flow
Cash Flow Yield
0.08
Income Statement
Total Revenue
1.36B
Operating Revenue Per Share
26.47
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
MOVEMovano Inc16.74+9.77+140.17%-- 
ABTAbbott Laboratories107.42-1.19-1.10%13.69PE
BSXBoston Scientific Corp92.51+1.22+1.34%48.82PE
MDTMedtronic plc100.88-0.46-0.45%27.46PE
PFSAProfusa Inc0.114-0.0014-1.21%-- 
Industry overview quotes are at least 15 minutes delayed
Business Description
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, thecompany operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.